<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Anderson M</submitter><funding>Canadian Institutes of Health Research</funding><funding>CIHR</funding><pagination>810-820</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6267642</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>109(5-6)</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>A small proportion of the population accounts for the majority of healthcare costs. Mental health and addiction (MHA) patients are consistently high-cost. We aimed to delineate factors amenable to public health action that may reduce high-cost use among a cohort of MHA clients in Saskatoon, Saskatchewan.&lt;h4>Methods&lt;/h4>We conducted a population-based retrospective cohort study. Administrative health data from fiscal years (FY) 2009-2015, linked at the individual level, were analyzed (n = 129,932). The outcome of interest was ≥ 90th percentile of costs for each year under study ('persistent high-cost use'). Descriptive analyses were followed by logistic regression modelling; the latter excluded long-term care residents.&lt;h4>Results&lt;/h4>The average healthcare cost among study cohort members in FY 2009 was ~ $2300; for high-cost users it was ~ $19,000. Individuals with unstable housing and hospitalization(s) had increased risk of persistent high-cost use; both of these effects were more pronounced as comorbidities increased. Patients with schizophrenia, particularly those under 50 years old, had increased probability of persistent high-cost use. The probability of persistent high-cost use decreased with good connection to a primary care provider; this effect was more pronounced as the number of mental health conditions increased.&lt;h4>Conclusion&lt;/h4>Despite constituting only 5% of the study cohort, persistent high-cost MHA clients (n = 6455) accounted for ~ 35% of total costs. Efforts to reduce high-cost use should focus on reduction of multimorbidity, connection to a primary care provider (particularly for those with more than one MHA), young patients with schizophrenia, and adequately addressing housing stability.</pubmed_abstract><journal>Canadian journal of public health = Revue canadienne de sante publique</journal><pubmed_title>The effect of socio-demographic factors on mental health and addiction high-cost use: a retrospective, population-based study in Saskatchewan.</pubmed_title><pmcid>PMC6267642</pmcid><funding_grant_id>2015-04-30</funding_grant_id><pubmed_authors>Stryhn H</pubmed_authors><pubmed_authors>Anderson M</pubmed_authors><pubmed_authors>Revie CW</pubmed_authors><pubmed_authors>Quail JM</pubmed_authors><pubmed_authors>Osman M</pubmed_authors><pubmed_authors>de Oliveira C</pubmed_authors><pubmed_authors>Buckeridge D</pubmed_authors><pubmed_authors>Wodchis W</pubmed_authors><pubmed_authors>Baetz M</pubmed_authors><pubmed_authors>McClure J</pubmed_authors><pubmed_authors>Neudorf C</pubmed_authors></additional><is_claimable>false</is_claimable><name>The effect of socio-demographic factors on mental health and addiction high-cost use: a retrospective, population-based study in Saskatchewan.</name><description>&lt;h4>Objective&lt;/h4>A small proportion of the population accounts for the majority of healthcare costs. Mental health and addiction (MHA) patients are consistently high-cost. We aimed to delineate factors amenable to public health action that may reduce high-cost use among a cohort of MHA clients in Saskatoon, Saskatchewan.&lt;h4>Methods&lt;/h4>We conducted a population-based retrospective cohort study. Administrative health data from fiscal years (FY) 2009-2015, linked at the individual level, were analyzed (n = 129,932). The outcome of interest was ≥ 90th percentile of costs for each year under study ('persistent high-cost use'). Descriptive analyses were followed by logistic regression modelling; the latter excluded long-term care residents.&lt;h4>Results&lt;/h4>The average healthcare cost among study cohort members in FY 2009 was ~ $2300; for high-cost users it was ~ $19,000. Individuals with unstable housing and hospitalization(s) had increased risk of persistent high-cost use; both of these effects were more pronounced as comorbidities increased. Patients with schizophrenia, particularly those under 50 years old, had increased probability of persistent high-cost use. The probability of persistent high-cost use decreased with good connection to a primary care provider; this effect was more pronounced as the number of mental health conditions increased.&lt;h4>Conclusion&lt;/h4>Despite constituting only 5% of the study cohort, persistent high-cost MHA clients (n = 6455) accounted for ~ 35% of total costs. Efforts to reduce high-cost use should focus on reduction of multimorbidity, connection to a primary care provider (particularly for those with more than one MHA), young patients with schizophrenia, and adequately addressing housing stability.</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Dec</publication><modification>2024-11-21T06:29:16.649Z</modification><creation>2019-03-27T00:11:07Z</creation></dates><accession>S-EPMC6267642</accession><cross_references><pubmed>29981109</pubmed><doi>10.17269/s41997-018-0101-2</doi></cross_references></HashMap>